Hartmann + Glucose, Viaflo Baxter (Potassium Chloride, Sodium Chloride, Calcium Chloride Dihydrate, Glucose, Sodium Lactate)

Hartmann + Glucose is used in a variety of clinical situations where fluid, electrolyte, and energy replacement are needed.

• Fluid replacement in hypovolemia or shock.
• Electrolyte replenishment during dehydration or electrolyte loss.
• Post‑operative hydration to support recovery after surgery.
• Intra‑operative volume expansion during major surgical procedures.
• Maintenance therapy for patients receiving parenteral nutrition.
• Support for patients with metabolic acidosis when combined with appropriate therapy.

Adverse reactions to Hartmann + Glucose are generally infrequent, but they can be categorized by frequency and severity.

Common

• Mild infusion site irritation or erythema.
• Transient hyperglycemia in patients with impaired glucose tolerance.
• Slight electrolyte disturbances such as mild hypernatremia or hypokalemia.
• Low‑grade fever or chills during rapid infusion.
• Local phlebitis at the catheter site.

Serious

• Severe hyperkalemia leading to cardiac arrhythmia.
• Fluid overload causing pulmonary edema.
• Anaphylactic or severe allergic reaction to solution components.
• Severe metabolic acidosis.
• Life‑threatening cardiac arrhythmias due to electrolyte imbalance.

When prescribing or administering Hartmann + Glucose, clinicians should observe several precautionary measures to minimize risk.

• Assess baseline electrolyte levels and renal function before infusion.
• Adjust infusion rate in patients at risk of fluid overload, such as heart failure or renal insufficiency.
• Monitor blood glucose in diabetic or critically ill patients.
• Avoid rapid large‑volume bolus unless clinically indicated.
• Use aseptic technique to prevent contamination of the IV bag.
• Consider compatibility with other IV medications before co‑administration.
• Document any adverse reactions promptly.

Hartmann + Glucose may interact with other drugs or solutions; awareness of these interactions helps ensure safe use.

Avoid

• Concurrent administration of potassium‑sparing diuretics or ACE inhibitors in patients with impaired renal function (risk of hyperkalemia).
• Co‑infusion with calcium‑containing solutions that are not compatible (risk of precipitation).
• Use with high‑dose insulin without glucose monitoring (risk of hypoglycemia).

Use with caution

• Simultaneous IV antibiotics that may cause incompatibility (e.g., ceftriaxone).
• Blood products that require separate lines to avoid mixing.
• Medications that affect fluid balance such as mannitol or hypertonic saline.
• Vasopressors that may alter hemodynamics during rapid infusion.